Bottom line
Is IZRL a good fund? The bottom line
IZRL is an actively managed technology sector ETF from ARK Invest.
It charges 0.49% — about $49 a year on every $10,000 invested, cheaper than 80% of technology sector funds we track.
It returned +15.5% over one year, +0.3% a year over five years (as of Dec 31, 2024, per its prospectus).
With $137 million in net assets and 66 holdings, its largest position is Teva Pharmaceutical Industries Ltd (1.8%) and the top 10 make up 16.9% of the portfolio.
What stands out
- Low cost: cheaper than 80% of technology sector peers
What to watch
- 5-year return in the bottom quarter of its category
Updated Nov 19, 2026
What IZRL invests in
The ARK Israel Innovative Technology ETF (Fund) seeks to provide investment results that closely correspond, before fees and expenses, to the performance of the ARK Israeli Innovation Index (Index).
The Fund normally invests at least 80% of its total assets in securities that are included in the Funds benchmark Index, depositary receipts representing securities included in the Index or underlying stocks in respect of depositary receipts included in the Index. This 80% investment policy is non -fundamental and may be changed without shareholder approval upon 60 days prior written notice to shareholders. The Index is designed to track the price movements of exchange listed Israeli Companies (as defined herein) whose main business operations are causing disruptive innovation in the areas of genomics, health care, biotechnology, industrials, manufacturing, the Internet or information technology. The Index has been created and licensed to the Fund by ARKs Index Products Group and is calculated, published and distributed by Solactive AG (Solactive). Information regarding the Index is…
From the fund's prospectus (filed Nov 26, 2025).
IZRL performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| IZRL | +15.5% | +0.3% | — |
| Technology Sector median | +24.0% | +10.0% | +16.7% |
Source: Fund prospectus, as of Dec 31, 2024
What IZRL costs
On a $10,000 investment, IZRL's 0.49% expense ratio costs about $49 a year. The prospectus estimates $616 in total costs over 10 years (assuming 5% annual returns). The median technology sector fund charges 0.75%.
IZRL top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Teva Pharmaceutical Industries Ltd TEVA | 1.76% |
| 2 | Pagaya Technologies Ltd PGY | 1.74% |
| 3 | Monday.com Ltd MNDY | 1.74% |
| 4 | Elbit Systems Ltd ESLT | 1.71% |
| 5 | Pcb Technologies Ltd PCBT | 1.70% |
| 6 | Sol-gel Technologies Ltd SLGL | 1.70% |
| 7 | Nayax Ltd NYAX | 1.67% |
| 8 | Wix.com Ltd WIX | 1.65% |
| 9 | Brainsway Ltd BWAY | 1.63% |
| 10 | Similarweb Ltd SMWB | 1.61% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 16.9% of the fund. See all top 25 holdings and asset mix →